Editor’s Spotlight/Take 5: Is Low-value Testing Before Low-risk Hand Surgery Associated With Increased Downstream Healthcare Use and Reimbursements? A National Claims Database Analysis

View Full Paper

Ask AI

Bookmark

Why the study?

Is low-value testing before low-risk hand surgery associated with increased downstream healthcare use and costs?

Population

Patients undergoing minor hand surgery (n=~70,000)

Design

Editorial

Authors

Discussion

Low-value preoperative testing before minor hand surgery triggers a cascade of further unnecessary testing and increased healthcare costs.

Is low-value testing before low-risk hand surgery associated with increased downstream healthcare use and costs?

Population

Patients undergoing minor hand surgery (n=~70,000)

Intervention

Low-value preoperative diagnostic testing

Outcome

Downstream healthcare use (future testing) and reimbursements/costs

Low-value preoperative testing before minor hand surgery triggers a cascade of further unnecessary testing and increased healthcare costs.

Seth S. Leopold (2022) studied this question.

View Full Paper

Ask AI

Bookmark

Low-value preoperative testing before minor hand surgery triggers a cascade of further unnecessary testing and increased healthcare costs.